Hans Boehling

Title: Innovations of Hans Boehling in Recombinant Polypeptide Production

Introduction

Hans Boehling is a notable inventor based in Kufstein, Austria. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant polypeptides. His work has implications for various applications in medicine and research.

Latest Patents

Hans Boehling holds a patent for "Expression vectors, transformed host cells and fermentation process for the production of recombinant polypeptides." This invention relates to an expression vector that includes a polynucleotide encoding a fusion protein. The fusion protein comprises the signal sequence of the gac gene and a polypeptide of interest. Additionally, it involves a prokaryotic host cell transformed with such an expression vector and a process for producing a polypeptide of interest using the host cell and expression vector. He has 1 patent to his name.

Career Highlights

Hans Boehling is associated with Sandoz AG, a global leader in generic pharmaceuticals and biosimilars. His role at the company has allowed him to work on innovative solutions that enhance the production of therapeutic proteins.

Collaborations

Some of his notable coworkers include Jörg Windisch and Kurt Schoergendorfer. Their collaborative efforts have contributed to advancements in the field of biotechnology.

Conclusion

Hans Boehling's innovations in recombinant polypeptide production highlight his expertise and commitment to advancing biotechnology. His contributions continue to influence the industry and pave the way for future developments.